Updating results

17 results for Copyright

Sort: Relevance | Date

Familial breast cancer. Taking a medicine to reduce the chance of developing breast cancer – Decision aid for postmenopausal women at moderately increased risk

developing breast cancer: patient decision aid (postmenopausal moderate risk) Copyright c NICE 2017. All rights reserved. Last updated...

Published March 2017 Last updated March 2017

Familial breast cancer. Taking a medicine to reduce the chance of developing breast cancer – Decision aid for postmenopausal women at high risk

developing breast cancer: patient decision aid (postmenopausal high risk women) Copyright c NICE 2017. All rights reserved. Last updated...

Published March 2017 Last updated March 2017

Freedom of Information

Freedom of Information

Published August 2019 Last updated August 2019

Familial breast cancer. Taking tamoxifen to reduce the chance of developing breast cancer – Decision aid for premenopausal women at moderately increased risk

developing breast cancer: patient decision aid (premenopausal moderate risk) Copyright c NICE 2017. All rights reserved. Last updated...

Published March 2017 Last updated March 2017

Familial breast cancer. Taking tamoxifen to reduce the chance of developing breast cancer – Decision aid for premenopausal women at high risk

developing breast cancer: patient decision aid (premenopausal high risk women) Copyright c NICE 2017. All rights reserved. Last updated...

Published March 2017 Last updated March 2017

Freedom of information publication scheme

decisions Our policies and procedures Lists and registers Services we offer Copyright Our publication scheme lists all of the...

Published September 2019 Last updated September 2019

NICE UK Open Content Licence

Our licence allows individuals, commercial organisations and non-commercial organisations to reuse NICE content free of charge in their publications, products and systems.

Published September 2019 Last updated September 2019

Ulcerative colitis: management (NG130)

This guideline covers the management of ulcerative colitis in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.

NICE guideline Published May 2019

Terms and conditions

Terms and conditions for the National Institute for Health and Care Excellence

Published September 2019 Last updated September 2019

Thank you we've received your form

third-party content. If this is the case you will need to contact the copyright owner(s) directly. Content assurance service Our expert...

Published March 2017 Last updated March 2017

Imagery

domain). If that's not possible, use paid for stock art sites to avoid copyright infringement. Examples of good photography

Published January 2017 Last updated January 2017

Intravenous fluid therapy in adults in hospital (CG174)

This guideline covers the general principles for managing intravenous (IV) fluid therapy in hospital inpatients aged 16 and over with a range of conditions. It aims to help prescribers understand the optimal amount and composition of IV fluids to be administered and the best rate at which to give them, to improve fluid prescribing and outcomes among people in hospital. It does not cover pregnant women, and those with severe liver or renal disease, diabetes or burns.

Clinical guideline Published December 2013 Last updated May 2017

Smoking cessation in secondary care

Everything NICE has said on helping people to stop smoking in secondary care in an interactive flowchart

NICE Pathway Published November 2013 Last updated May 2017

Ulcerative colitis

Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart

NICE Pathway Published June 2013 Last updated September 2019

Smoking

Everything NICE has said on preventing the uptake of smoking and helping people to stop smoking in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Obese, overweight with risk factors: liraglutide (Saxenda) (ES14)

Summary of the evidence on liraglutide for managing obesity and overweight with risk factors in adults to inform local NHS planning and decision-making

Evidence summary Published June 2017

Guide to the processes of technology appraisal (PMG19)

Guide to the processes of technology appraisal

Published September 2014 Last updated May 2018 Last updated May 2018